BioBAT Company Profiles
Biotia is a health tech company, launched from Cornell Tech and Weill Cornell Medicine,
that leverages DNA sequencing-based technology and proprietary AI-powered software
to rapidly and accurately identify microorganisms and antimicrobial resistance. Their
mission is to fight infectious disease by deploying the leading reference library
of microbes worldwide.
Calder is a private biotechnology company applying proprietary technologies to develop
conformationally locked, improved subunit vaccine immunogens. The company's technologies
enhance the performance of these products by stabilizing their conformations, which
then better represent the 3-D structure of these proteins on the surface of the pathogen,
and therefore give rise to more protective antibody responses.
Chemitope Glycopeptide, LLC, or Chemitope, is a boutique biotech company that aims
to produce a new generation of preventative vaccines. Chemitope was founded by Dr.
Baptiste Aussedat and Dr. William Walkowicz, two PhD scientists at Memorial Sloan
Kettering Cancer Center in New York City, to meet the current and future demand for
homogeneous glycopeptides in the ongoing effort to develop an HIV vaccine.
CortecNet distributes Nuclear Magnetic Resonance (NMR) consumables and stable isotope
enriched compounds. The company provides various consumables, including NMR tubes
and NMR rotors. Cortecnet also provides stable isotope enriched products, including
deuterated solvents, uniformly and selectively labeled amino acids, uniformly and
selectively labeled carbohydrates, isotopic gases, metal isotopes, deuterated lipids
and labeled protein standards. In addition, CortecNet offers biological products,
such as antibodies, elisa kits, and molecular biology from ADI; analytical products,
including, NMR, EPR consumables, seringes and GC columns from SGE, UV-Visible / IR
consumables, CHN,O,S;AAS;ICP/ICP-MS consumables.
IAVI's Vaccine Design and Development Laboratory (DDL) is a versatile facility designed
to create novel immunogens, develop viral vectors, evaluate potency and advance promising
candidates to clinical evaluation. The DDL has also established common preclinical
standards for the vaccine field. Their goals are to understand the basis of naturally
evoked, broadly neutralizing antibodies against HIV and other Emerging Infectious
Diseases (EID) such as, but not limited to, Lassa fever, Marburg virus, and Covid-19.
The Interstate Environmental Commission (IEC) is a tri-state water and air pollution
control agency committed to protecting, conserving, and restoring the environment
in the Interstate Environmental District, particularly in the area of water quality.
IEC seeks to achieve this goal through cooperation, regulation, coordination, and
mutual dialogue between government and citizens in the Tri-State Region.
RegenLab is recognized as a certified global leader in medical biotechnologies, specializing
in cellular therapies. RegenLab® is at the forefront of innovation, with an expertly
designed medical device for the preparation of platelet rich plasma from the patient's
own blood. Regen® A-PRP® was developed with a focus on product quality, patient safety,
and preparation efficiency. Our patient-centered technology has led to over one million
treatments provided worldwide using RegenLab® products. As we look to the future,
we are committed to guiding new standards for emerging categories within the field
of regenerative medicine.
Keel Labs, formerly known as AlgiKnit, is a biomaterials company integrating science
and design into textile production. Addressing the ecological damage caused by the
fashion industry, AlgiKnit is creating durable yet rapidly degradable yarns. AlgiKnit
envisions the next generation of sustainable, wearable and ethical materials, produced
within a closed-loop life cycle.
Allied Microbiota was founded to bring low-cost sustainable solutions to treat recalcitrant
pollutants using environmentally friendly microbial solutions. Founded in 2017 by
Dr. Ray Sambrotto and Frana James from Columbia University, Allied Microbiota has
developed methods of bioremediation using naturally isolated bacterial cultures and
their enzymes for remediation of soil, sediments and groundwater using techniques
like composting, and flow through reactors. Offering great advantages to expensive
treatments for recalcitrant remediation, the company's microbes provide users with
remarkable cost savings, reducing PCB levels by 80 percent in few days. It is also
expanding its focus on improving the fermentation process and strain development to
develop new bio-chemicals and enzymes for industrial and environmental applications.
Eterna, formerly known as Brooklyn ITX, is a clinical-stage bioresearch company developing
IRX-2, an important new immunotherapy candidate for cancer. Eterna is developing novel
immunotherapies based upon reversing immune suppression that is typically seen in
patients with cancer and other diseases. The lead product, IRX-2, is a primary cell-derived
biologic with multiple active cytokine components that acts on multiple cell types
of the immune system including T cells, dendritic cells, and natural killer cells.
Fork & Good is developing new approaches to growing animal cells to create delicious
and healthy meat products. This addresses critical food safety issues, cuts out the
immense resource needs for livestock, and avoids animal slaughter to help meet our
growing protein needs. Fork & Good intends to do this using cell culture technology
to actually grow meat cells to have the flavor that we crave and the key nutrients
we need (vs. pure plant-based substitutes).
Modern Meadow develops cultured animal products including leather, food and other
applications without the need for harming animals or the environment. By leveraging
the latest advances in biotechnology and bio fabrication, the Company is able to make
better materials and animal products with demonstrated advantages for design, performance,
manufacturing and sustainability.